Navigation Links
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
Date:6/17/2013

asonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to, (1) the economic circumstances surrounding Takeda's business, including general economic conditions in Japan, the United States and worldwide; (2) competitive pressures and developments; (3) applicable laws and regulations; (4) the success or failure of product development programs; (5) actions of regulatory authorities and the timing thereof; (6) changes in exchange rates; (7) claims or concerns regarding the safety or efficacy of marketed products or product candidates in development; and (8) integration activities with acquired companies.

The forward-looking statements contained in this press release speak only as of the date of this press release, and Takeda undertakes no obligation to revise or update any forward-looking statements to reflect new information, future events or circumstances after the date of the forward-looking statement. If Takeda does update or correct one or more of these statements, investors and others should not conclude that Takeda will make additional updates or corrections.


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Calif. , Sept. 23, 2014 Avanir Pharmaceuticals, ... pricing of a public offering of 18,200,000 shares of ... a price to the public of $11.00 per share, ... BofA Merrill Lynch are acting as joint book-running managers ... Securities are acting as co-managers for the offering. Avanir ...
(Date:9/23/2014)... Therapeutics, Inc. (NASDAQ: ECTE ), a ... believes that its current liquidity is insufficient to ... has suspended its product development, research, manufacturing and ... and capital resources. The actions ... position, funding alternatives, and projected product development costs ...
(Date:9/23/2014)... Sept. 23, 2014 Market Snapshot: Transcatheter Heart Valve 2007 to 2020 ... France , Italy , UK, Spain ... to 2020 - Europe ( Germany , ... Spain )" provides quantitative analysis of the transcatheter heart valves market in ... and volume over the 2007–2020 period and key company share data by revenue ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3Echo Therapeutics Suspends Operations To Conserve Liquidity 2Echo Therapeutics Suspends Operations To Conserve Liquidity 3Echo Therapeutics Suspends Operations To Conserve Liquidity 4Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2
... - Ambrilia,Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing,novel ... and,cancer, held its Annual General and Special Meeting ... novel series of HIV,integrase inhibitors and recent developments ... Chairman of the Board, Mr. Frederic,Porte, and a ...
... 2007 /PRNewswire/ -- Results of the,Option (TOcilizumab ... first multinational Phase III study outside,of Japan, ... 4mg/kg,or 8mg/kg) plus methotrexate achieved a significant ... symptoms of moderate to,severe rheumatoid arthritis (RA) ...
Cached Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
(Date:9/23/2014)... New York (PRWEB) September 23, 2014 ... serious injury due to spontaneous migration of the birth ... U.S., Bernstein Liebhard LLP reports. According to court documents ... complaint that alleges migration of the IUD outside of ... her rectum. Her lawsuit, which is now pending in ...
(Date:9/23/2014)... 2014 Oaksterdam University has begun publishing ... its first post, the University addresses the need for ... industry. , The cannabis industry is becoming big business. ... an 18-month boost of more than $600 million in ... sales. And, the new legal recreational marijuana market in ...
(Date:9/23/2014)... studies found that FDG-PET technology is less accurate ... regions where infections like histoplasmosis or tuberculosis are ... cancer could lead to unnecessary tests and surgeries ... , Histoplasmosis and other fungal diseases are ... bird droppings and are found in soils. , ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows ... how it can be treated. , A medically retired ... 2006. His platoon sustained multiple attacks resulting in five ... with combat-related PTSD and honorably discharged from the Army. ... had distanced myself from my friends and family,” recalled ...
(Date:9/23/2014)... Doheny HealthDay Reporter TUESDAY, ... very low birth weights, breast milk is more likely than ... known as cytomegalovirus (CMV), a new study finds. The ... -- all of whom weighed 3.3 pounds or less and ... CMV infection, to see whether breast milk or transfusions carried ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3
... overtime pay to Home Health,employees, CHICAGO, April 24 ... the state Department of Labor has,forwarded the wage complaint ... to the Office of the Attorney General for prosecution. ... Care owes $381,000 in back wages to 64 Home ...
... Care Closer to Veterans, WASHINGTON, April 24 ... for Denver-area residents and veterans may result from ... (VA), the,University of Colorado Denver and the University ... be built on University property at the former,Fitzsimons ...
... of Organization,s DC-Based Legislative,Initiatives, WASHINGTON, April 24 ... department announced today the,appointment of Geoff Werth to ... Based in the organization,s Washington, D.C.,office, Werth will ... Hill,in order to advance public policies designed to ...
... you are in pecking order affects performance, motivation ... how the brain processes social status is outlined in a ... Health (NIMH). , Using functional MRI scans, they found that ... or down in social status or sees people who are ...
... 24 /PRNewswire-FirstCall/,-- MedeFile International, Inc. (OTC Bulletin Board: MDFI), ... with Dr. Lorne S. Stitsky, "The House Call Doc," ... the Official Grand Opening of Personal,Choice Family Practice (PCFP), ... WHEN: Friday, May 2, ...
... video footage from Labor Notes conference shows nonviolent,protest ... inaccurate and,exaggerated, WASHINGTON, April 24 With ... MI, showing a nonviolent protest held,by mostly women ... nurse Dian Palmer today called on AFL-CIO President ...
Cached Medicine News:Health News:Wage Complaint Forwarded to Attorney General for Prosecution 2Health News:VA, UCH, UC Denver Partner for New Bed Tower, Expanded Services 2Health News:US Oncology Welcomes New Director of Federal Government Relations 2Health News:Social Status Plays Role in Brain's Control of Health 2Health News:MedeFile and Dr. Lorne Stitsky Host 'Open House' at Personal Choice Family Practice in Jupiter, Florida 2Health News:MedeFile and Dr. Lorne Stitsky Host 'Open House' at Personal Choice Family Practice in Jupiter, Florida 3Health News:SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions 2Health News:SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions 3
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: